Somalogic stock.

SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. …Income Statement for Somalogic Inc (SLGC) with Annual and Quarterly reports. Income Statement for Somalogic Inc (SLGC) ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.Oct 4, 2023 · Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ... SomaLogic Inc (NASDAQ: SLGC)’s stock price has gone rise by 4.09 in comparison to its previous close of 2.20, however, the company has experienced a 5.77% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-31 that BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics […]Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 million, according to its latest 13F filing. The imputed share price was $2.90. SLGC has a 0.2% weight in ARK Invest and a 1.12% weight in ARK Genomic Revolution ETF (ARKG). ARK owns 4.97% of the company.

Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money.

Nov 18, 2022 · With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ... If you hold stock certificates in your name, please contact our transfer agent, Continental, at 1-877-634-5370. ... Does SomaLogic have a direct stock purchase plan?

With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Standard BioTools Inc. and SomaLogic, Inc. is fair to Standard BioTools shareholders. Under the terms of the...Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ...

Nov 17, 2023 · The SomaLogic, Inc. stock price gained 1.62% on the last trading day (Friday, 17th Nov 2023), rising from $2.47 to $2.51. During the last trading day the stock fluctuated 3.48% from a day low at $2.44 to a day high of $2.53. The price has been going up and down for this period, and there has been a 11.06% gain for the last 2 weeks.

Another stock from the same industry, SomaLogic, Inc. (SLGC), has yet to report results for the quarter ended December 2022. The results are expected to be released on March 28.

SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 10% and 113.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Nov 18, 2022 · With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ... Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ...

Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2 ...SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.0001837412 false 0001837412 2023-10-04 2023-10-04 0001837412 us-gaap:CommonClassAMem...Dec 4, 2023 · Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money. Mar 28, 2023 · SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook. In connection with …Somalogic story: Study finds proteomic risk scores for cardiovascular disease from SomaSignal Cardio DM tests could support physicians in managing patient outcomes and other headlines for Somalogic Stock

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.EBITDA Margin. -. -. -167.22%. Created with Highstock 2.1.8. SomaLogic Inc. Annual stock financials by MarketWatch. View the latest SLGC financial statements, income statements and financial ratios.View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ...The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in …

SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...

SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.

Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook SomaLogic, Inc. (NasdaqGM:SLGC) entered into a definitive agreement to acquire to acquire Standard BioTools Inc. (NasdaqGS:LAB) from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP, managed by Viking Global Investors LP and others for approximately $570 million in a reverse merger transaction on October 4, 2023.Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...4 oct 2023 ... Investors in Colorado-based SomaLogic will get 1.11 shares of Standard BioTools stock for each share they own. They'll own about 57% of the ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0.001 per …SomaLogic common stock is traded on the Nasdaq exchange under the symbol SLGC, and SomaLogic warrants are traded on the Nasdaq under the symbol SLGCW. Does SomaLogic pay dividends? SomaLogic does not expect to declare or pay any cash or other dividends on its common stock.In conjunction with the announcement, Standard Bio raised its full-year guidance to $100M–$105M, while SomaLogic reaffirmed its 2023 guidance at $80M–$84M. More on Standard Bio, SomaLogic, etc.SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ...SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...Are hedge funds shorting SomaLogic (NASDAQ:SLGCW) stock? View the latest SLGCW short interest ratio, short volume, and more at MarketBeat. Skip to main content. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. The bottom is in for this beaten-down retailer. Secure your stake in the Smart Home industry.Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors common stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other than

Nov 22, 2023 · Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.12/04/2023 - 08:00 AM. SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the ...Instagram:https://instagram. 1yr t billhow much is a brioni suitmagnifi ai investmentmain 401k companies BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market ... aetna dental savings plan reviewinvesco canada Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a … stock blogs Real time SomaLogic (SLGC) stock price quote, stock graph, news & analysis. Dec 1, 2023 · 5 Wall Street analysts have issued 1-year price targets for SomaLogic's shares. Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a possible upside of 56.0% from the stock's current price. View analysts price targets for SLGC or view top ...